Skip to main content

Featured

Canadian Money Brief: 5 Things to Know Today — Tuesday, May 19, 2026

  From Canada's surprise rise to near the top of G7 growth charts, to softening rents, a cooling job market, and a looming trade renegotiation with the U.S. — here's what's moving your money today. 1 Economy & Growth Canada Is the 2nd-Fastest Growing G7 Economy — But Headwinds Loom The IMF now projects Canada to post the 2nd-fastest GDP growth in the G7 for 2026–2027, and the Spring 2026 Economic Update backs that up: the economy grew 1.7% in 2025 while avoiding a recession. Business investment is rebounding — up 2.6% in Q4 2025 — and Canada has attracted a record $97 billion in foreign direct investment. The engine? A relative tariff advantage under CUSMA, strong energy exports, and targeted federal spending. The caution: that momentum is fragile. Higher oil prices, a soft labour market, and a critical U.S. trade review mid-year could all shift the outlook quickly. 💡 What it means for you A growing economy generally supports job stability and wage gains — but don...
Post a Comment
Read more

article

Labels

Federal Government Boosts Vaccine Injury Compensation Fund with Additional $36 Million

 

The Canadian federal government has recently allocated an additional $36.4 million to the Vaccine Injury Compensation Fund, a program designed to support individuals who have experienced serious injuries or fatalities related to vaccines since the end of 2020. Here are the key details:

  1. Purpose of the Fund:

    • The program was established shortly after COVID-19 vaccines became available to the public.
    • It provides financial compensation to people who suffered adverse effects due to Health Canada-approved vaccines.
    • The goal is to assist those who were seriously impacted by vaccination.

  2. Funding and Administration:

    • The Liberal government initially earmarked $75 million for the first five years of the program.
    • A private firm called OXARO manages the program and disburses valid claims originating outside of Quebec.
    • To date, OXARO has received $56.2 million from Ottawa and has paid out $11.2 million in compensation.
    • Quebec has its own vaccine injury compensation program, which received $7.75 million when the federal program launched.

  3. Recent Funding Boost:

    • As part of the federal budget, the government allocated an additional $36 million to OXARO and Quebec.
    • This funding covers the next two years of the program.
    • The Public Health Agency of Canada contracted OXARO to ensure an impartial claims process.

  4. Eligibility and Claims:

    • The program covers injuries and deaths associated with vaccines approved for any illness.
    • Eligibility criteria include severe, life-threatening, or life-altering injuries resulting in disability, incapacity, birth defects, or death.
    • The available statistics do not specify which vaccines were involved.

  5. Rare Adverse Reactions:

    • Serious adverse reactions to vaccines are extremely rare (affecting less than one in a million people).
    • Nevertheless, the government recognizes its duty to provide support when such reactions occur.
    • Ottawa has also made COVID-19 vaccination mandatory for travel and federal public service employment.

In summary, the additional funding aims to ensure that those affected by vaccine-related injuries receive appropriate compensation while maintaining an impartial claims process. The program underscores the importance of vaccine safety and accountability in public health efforts. 


Labels:

Comments

Post a Comment